BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center
Israeli govt signs agreement with BioNTech to build R&D center for mRNA-based vaccines in Jerusalem.
Israeli govt signs agreement with BioNTech to build R&D center for mRNA-based vaccines in Jerusalem.
When later confronted with the recording, employee panics and turns violent.
Pfizer's animal trials showed mRNA spreads through the body, but most scientists denied the possibility of the same occurring in humans.
Pfizer executive Janine Small says company had to 'move at the speed of science' in EU Parliament hearing.
European parliamentarians don't even know how much the EU paid Pfizer for the shots.
Hebrew U and Volcani Institute, team up to prevent looming global food crisis: New biological sensor detects hidden disease in potatoes.
Double-boostered & now on 2nd course of Paxlovid.
New study shows over 8 per 10,000 net increase in hospitalization following vaccination.
Key COVID vaccine producer to cease supplying Russia, putting strain on Russian pharma companies.
Dr. John Campbell analyzes Pfizer data used by FDA to license COVID shot, detailing adverse effects in first months of its use.
Expiration date for some 250,000 shots reportedly extended by two weeks amid major decline in demand for the shots.
A new method of characterizing immune cells shed in the stool could facilitate diagnosis and improve treatment of inflammatory bowel disease
US district judge rules FDA must produce 55,000 pages of Pfizer data per month, rejecting FDA request to produce only 500 pages per month.
FDA report shows Pfizer's clinical trials found 24% higher all-cause mortality rate among the vaccinated compared to placebo group.
Health Min. to purchase thousands of doses of new anti-coronavirus drug - but only after FDA approval, report says.
New experimental COVID pill, which uses low dose of HIV drug, is said to cut risk of death for high-risk patients by 89%.
Pfizer says it expects $36 billion in sales from COVID shot in 2021 and another $29 billion in 2022.
Dave Rubin shares video highlighting Pfizer’s conflict of interest with the news media.
Israeli PM speaks with Pfizer CEO Albert Bourla about possibility of vaccinating children under 12, providing 3rd vaccine doses.
Europe's drugs regulator said it was looking into three new conditions reported by a small number of recipients of Pfizer and Moderna shots.
Researchers who led serological study which tipped the scale in favor of a third dose of vaccines received funding from Pfizer, report says.
Opposition leader says after talking with Pfizer CEO and other experts that the over-50 population must receive a 3rd vaccine shot.
Officials meet with Pfizer representatives, conclude no need for fully vaccinated citizens to get another jab at this time.
An Israeli study found that the vaccine is substantially less effective against the more infectious delta strain, raising new questions.
Israeli PM speaks with Pfizer CEO in bid to solve 'vaccine crisis', including possible trades.
Israel will have to throw out hundreds of thousands of vaccines which are nearing their expiration date.
Pfizer working on vaccine with longer refrigerator life, will apply for approval to vaccinate younger children this fall, CEO says.
Netanyahu announced the purchase of millions of additional doses of Pfizer, Moderna vaccines ahead of 2nd round of COVID boosters.
Netanyahu, Pfizer CEO agreed on Independence Day on new deal which would circumvent Gantz veto.
New vaccines will ensure Israeli population maintains immunity against the coronavirus for the future.
Albert Bourla says people may have to receive the COVID vaccine every year to ensure immunity remains.
Head of Shaare Tzedek's Liver Unit discusses the Pfizer vaccine and the Israeli vaccine mission.
Pfizer fumes at Israel for delaying payment for previous vaccine shipment, halts shipments until issue is resolved.
Pharmaceutical giant stops deliveries pending Israeli government approval of new deals to purchase vaccines.
Pfizer-BioNTech vaccine is 91% effective, has no serious safety concerns, even six months after second dose, new findings show.
Many refuse to give the PM any credit for the success of Israel's vaccination campaign despite the words of Pfizer's CEO. Op Ed
Pfizer's oral COVID-19 antiviral therapy drug could be given to patients at the first sign of infection, the drug maker said on Tuesday.
Heads of major vaccine producers say they expect Israeli data to help the rest of the world beat COVID-19.
'A lot of indicators' tell us vaccine provides 'protection against the transmission' of coronavirus, Pfizer CEO Albert Bourla says.
'We believe the third dose will raise antibody response ten- to twenty-fold,' Pfizer CEO Albert Bourla says.